申请人:Meiji Seika Kaisha, Ltd.
公开号:EP1277737A1
公开(公告)日:2003-01-22
A substance having affinity for an opioid δ receptor, which is represented by the following general formula (I):
wherein, X represents a group of the general formula: -CO-N(R5)(R6) (II) and the like, n represents 1 to 3, R1 and R2 represent a hydrogen atom, a halogen atom, a lower alkyl group and the like, R3 represents a hydrogen atom, a halogen atom, a lower alkyl group and the like, R4 represents a saturated or unsaturated monocyclic or bicyclic carbocyclic group and the like, R5 to R12 represent a hydrogen atom, a lower alkyl group and the like, and R3 and R4, R5 and R6, R7 or R8 and R9 and R10 may bind to each other to form a cyclic structure, and a medicament useful for preventive and/or therapeutic treatment of central nervous system diseases and peripheral nervous system diseases comprising the substance as an active ingredient.
一种对阿片δ受体具有亲和力的物质,由以下通式(I)表示:
其中,X 代表通式中的基团:-R1 和 R2 代表氢原子、卤素原子、低级烷基等,R3 代表氢原子、卤素原子、低级烷基等,R4 代表饱和或不饱和的单环或双环碳环基团等,R5 至 R12 代表氢原子、低级烷基等、R3和R4、R5和R6、R7或R8以及R9和R10可以相互结合形成环状结构,以及一种用于预防和/或治疗中枢神经系统疾病和周围神经系统疾病的药物,该药物包含该物质作为活性成分。